« Back
Home /
Avelumab (anti-PD-L1)

Avelumab (anti-PD-L1)

€2,918.00

Excl. VAT

Item no.	A2015-25mg
Manufacturer	Selleckchem
CASRN	1537032-82-8
Amount	1 mg x 25
Category	Antibodies Primary Antibodies
Type	Antibody
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	Bavencio, MSB0010718C
Available
Information	Avelumab (anti-PD-L1) (Bavencio, MSB0010718C) is a fully human IgG1 monoclonal antibody that targets the protein programmed death-ligand 1 (PD-L1). Avelumab exhibits potential antibody-dependent cell-mediated cytotoxicity and is used for the treatment of several kinds of carcinoma. MW=143.8 kDa.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg x 25

Listprice: €2,918.00

Price: €2,918.00

available

Delivery expected until 9/4/2025

Quantity:

Compare